RecruitingAsthma AcuteAsthma ExacerbationAsthma
45th Multicenter Airway Research Collaboration
Eligible age
18–54 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Sponsor: Massachusetts General Hospital
You may qualify if…
- ✓ acute asthma
- ✓ age 18.0 to 54.9 years
- ✓ English and/or Spanish speaking
- ✓ decision by ED attending to discharge patient to home on short course of systemic corticosteroids
- ✓ (intervention group only) Willingness to use Airsupra as their rescue inhaler for next 3 months
- ✓ demonstration of acceptable MDI administration technique
- ✓ provision of informed consent prior to any study-specific procedures
You may not qualify if…
- ✕ involvement in the planning and/or conduct of the study
- ✕ previous enrolment in the present study
- ✕ prior diagnosis of COPD, chronic bronchitis, or emphysema
- ✕ use of systemic corticosteroids in the past 2 weeks
- ✕ participation in another clinical study with an investigational product during the past 4 weeks or the 3 months after enrollment in the current study
- ✕ concurrent pneumonia
- ✕ clinically significant cardiovascular disease or clinically significant cancer
- ✕ patients with known hypersensitivity to Airsupra, albuterol sulfate, budesonide, or any of the excipients of the product
Where it's recruiting
Ohio
Cleveland
Source: ClinicalTrials.gov · NCT07166939 · last updated 2026-04-17